EMA sticks to the recommendation of Astrazeneca's covid-vaccine

The EMA has announced that it sees a possible connection between Astrazeneca's Covid-19 vaccine and some highly rare cases of blood clots following vaccinations, but it maintains its recommendations to keep using the vaccine.

Photo: STAFF/REUTERS / X01095

The European Medicines Agency thinks that the advantages of the Astrazeneca vaccine against Covid-19 outweigh the disadvantages by far, states the agency at a press conference Wednesday afternoon.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs